International Stem Cell Corporation Completes First Cohort In Parkinson’s Disease Clinical Trial – P&T Community
P&T Community |
International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial
P&T Community CARLSBAD, Calif., April 25, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced that … StemGenex Recognizes Parkinson's Awareness Month |
